Fatheya Alawadi a , b , * , Salah Abusnana c , Bachar Afandi d , e , Khaled M. Aldahmani d , e , Omniyat Alhajeri f , g , Khaled Aljaberi h , Juma Alkaabi e , Abdulrazzaq Almadani i , Alaaeldin Bashier a , Salem A. Beshyah b , j , Buthaina bin Belaila k , Mohammad Fargaly b , l , Muhammad H. Farooqi b , m , Khadija Hafidh b , n , Mohamed Hassanein a , o , Ahmed Hassoun b , m , Abdul Jabbar p , q , r , Iyad Ksseiry q , s , Huda E. Mustafa e , t , Hussein Saadi u , Sara Suliman v , w
19 February 2020
Rapid urbanisation and socioeconomic development in the United Arab Emirates (UAE) have led to the widespread adoption of a sedentary lifestyle and Westernised diet in the local population and consequently a high prevalence of obesity and diabetes. In 2019, International Diabetes Federation statistics reported a diabetes prevalence rate of 16.3% for the adult population in the UAE. In view of the wealth of recent literature on diabetes care and new pharmacotherapeutics, the Emirates Diabetes Society convened a panel of experts to update existing local guidelines with international management recommendations. The goal is to improve the standard of care for people with diabetes through increased awareness of these management practices among healthcare providers licensed by national health authorities. These consensus guidelines address the screening, diagnosis and management of type 2 diabetes mellitus in adults including individuals at risk of developing the disease.